This Company has developed a Personalized App to Fight Cancer

November 4, 2016 - 1 minute

We say goodbye to the good weather in Spain and cross the Pyrenees to visit Charleroi, an industrial city south of Brussels. There, we find OncoDNA, a young company striving to change the oncology field using DNA.

OncoDNA logo

City: Charleroi, Belgium

Founded: 2012

Employees: 11 – 50

Financial data: €7.7M raised in September to expand into the global market

Content continues below

Related Content

OncoDNA CEO Jean-Pol Detiffe
Jean-Pol Detiffe, CEO

Mission: OncoDNA uses next-generation sequencing to analyze major DNA mutations in cancer and match the patient with a personalized treatment option. The coolest part is that the whole process can be controlled via a mobile app with a pretty neat design. On April, the company launched OncoTRACE, the first non-invasive personalized test to monitor tumor progression.

Comment: OncoDNA could pass for the smaller sibling of Foundation Medicine in the US. Jean-Pol Detiffe, its CEO, will be speaking at Labiotech Refresh this November. Don’t miss it!


You might also be interested in the following: